Four distinct biomarker statuses were identified: (1) “normal” (all biomarkers low/medium; except HDL-cholesterol; reference), (2) “low leptin/IGF-1/HbA1c”, (3) “dyslipidemia/high leptin” and (4) “inflammation”. This evidence concerns the gene IGF1 and metabolic syndrome.